Items where authors include "Siegbahn, A."

Article

Eggers, K.M. orcid.org/0000-0002-8806-5778, Batra, G., Lindahl, B. et al. (10 more authors) (2024) Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry and Laboratory Medicine (CCLM). ISSN 1434-6621

Batra, G., Renlund, H., Kunadian, V. et al. (9 more authors) (2022) Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome : results from the PLATelet inhibition and patients Outcomes (PLATO) trial. European Heart Journal. Acute Cardiovascular Care, 11 (4). pp. 336-349. ISSN 2048-8726

Gregersen, I., Michelsen, A.E., Lunde, N.N. et al. (17 more authors) (2020) Legumain in acute coronary syndromes: A substudy of the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American Heart Association, 9 (17). e016360. ISSN 2047-9980

Sumaya, W., Wallentin, L., James, S.K. et al. (5 more authors) (2020) Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: A PLATO sub-study. Thrombosis and Haemostasis, 120 (03). pp. 412-422. ISSN 0340-6245

Åkerblom, A., James, S.K., Lakic, T.G. et al. (9 more authors) (2019) Interleukin‐18 in patients with acute coronary syndromes. Clinical Cardiology, 42 (12). pp. 1202-1209. ISSN 0160-9289

Åkerblom, A., Wojdyla, D., Steg, P.G. et al. (9 more authors) (2019) Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes : insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Journal of Thrombosis and Thrombolysis, 48 (4). pp. 563-569. ISSN 0929-5305

Sumaya, W., Wallentin, L., James, S.K. et al. (6 more authors) (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. European Heart Journal . ehy013. ISSN 0195-668X

Ueland, T., Åkerblom, A., Ghukasyan, T. et al. (11 more authors) (2018) Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 7 (2). e007009.

Lowenstern, A., Storey, R.F. orcid.org/0000-0002-6677-6229, Neely, M. et al. (12 more authors) (2017) Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis, 44 (2). pp. 145-153. ISSN 0929-5305

Lindholm, D., Hagström, E., James, S.K. et al. (10 more authors) (2017) Growth differentiation factor 15 at 1 month after an acute coronary syndrome is associated with increased risk of major bleeding. Journal of the American Heart Association, 6 (4). ISSN 2047-9980

Proceedings Paper

Sumaya, W., Wallentin, L., James, S.K. et al. (6 more authors) (2018) Adverse fibrin clot properties are associated with worse outcome following acute coronary syndrome: a PLATO substudy. In: Circulation. American Heart Association's 2017 Scientific Sessions and Resuscitation Science Symposium, 11-15 Nov 2017, Anaheim, California. American Heart Association .